Autonomix Medical, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
Autonomix Medical (NASDAQ: AMIX), a medical device company specializing in precision nerve-targeted treatments, will participate in the upcoming Webull Financial Corporate Connect Webinar Series focused on Biotech/MedTech companies.
The virtual presentation will be delivered by Brad Hauser, President and CEO, on Thursday, August 21, 2025, at 2:20 PM ET. The event is part of a broader virtual conference taking place from August 19-21, 2025.
Autonomix Medical (NASDAQ: AMIX), azienda di dispositivi medici specializzata in terapie di precisione mirate ai nervi, parteciperà alla serie di webinar Webull Financial Corporate Connect dedicata alle società Biotech/MedTech.
La presentazione virtuale sarà tenuta da Brad Hauser, President e CEO, giovedì 21 agosto 2025 alle 14:20 ET. L'evento fa parte di una conferenza virtuale più ampia in programma dal 19 al 21 agosto 2025.
Autonomix Medical (NASDAQ: AMIX), compañía de dispositivos médicos especializada en tratamientos de precisión dirigidos a nervios, participará en la serie de seminarios web Webull Financial Corporate Connect centrada en empresas Biotech/MedTech.
La presentación virtual será impartida por Brad Hauser, presidente y CEO, el jueves 21 de agosto de 2025 a las 2:20 PM ET. El evento forma parte de una conferencia virtual más amplia que se celebra del 19 al 21 de agosto de 2025.
Autonomix Medical (NASDAQ: AMIX))는 신경 표적 정밀 치료를 전문으로 하는 의료기기 회사로, 바이오텍/메드텍 기업을 대상으로 한 Webull Financial Corporate Connect 웨비나 시리즈에 참여합니다.
가상 발표는 Brad Hauser 대표 겸 CEO가 2025년 8월 21일 목요일 동부시간(ET) 오후 2시 20분에 진행합니다. 이 행사는 2025년 8월 19일부터 21일까지 열리는 더 큰 가상 컨퍼런스의 일부입니다.
Autonomix Medical (NASDAQ: AMIX), une société de dispositifs médicaux spécialisée dans les traitements de précision ciblant les nerfs, participera à la série de webinaires Webull Financial Corporate Connect dédiée aux entreprises Biotech/MedTech.
La présentation virtuelle sera assurée par Brad Hauser, président et PDG, le jeudi 21 août 2025 à 14h20 ET. L'événement fait partie d'une conférence virtuelle plus large qui se déroulera du 19 au 21 août 2025.
Autonomix Medical (NASDAQ: AMIX), ein Medizintechnikunternehmen, das sich auf präzise, nervgezielte Therapien spezialisiert hat, wird an der bevorstehenden Webull Financial Corporate Connect Webinar-Reihe teilnehmen, die sich auf Biotech-/MedTech-Unternehmen konzentriert.
Die virtuelle Präsentation hält Brad Hauser, President und CEO, am Donnerstag, den 21. August 2025 um 14:20 Uhr ET. Die Veranstaltung ist Teil einer größeren virtuellen Konferenz, die vom 19. bis 21. August 2025 stattfindet.
- None.
- None.
– Live video webcast on Thursday, August 21st at 2:20 PM ET
THE WOODLANDS, TX, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted treatments, today announced that it will present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech being held virtually August 19-21, 2025.
Details for the presentation are as follows:
Date and Time: Thursday, August 21, 2025 at 2:20 PM ET
Presenter: Brad Hauser, President and Chief Executive Officer
Registration Link: HERE
About Webull Financial
Webull Financial is a leading online brokerage platform committed to empowering self-directed investors with innovative tools and cutting-edge technology. With low-cost trading on a wide range of assets, advanced charting tools, and real-time market data, Webull is revolutionizing the way individuals approach investing. The user-centric approach and commitment to staying at the forefront of industry trends underscore the mission to provide a seamless and rewarding experience for traders of all levels. Through the Webull Group, Webull Financial and its affiliates combine to serve tens of millions of users from over 180 countries worldwide. Securities and futures trading is offered to customers by Webull Financial LLC ("Webull Financial"), a broker-dealer registered with the Securities and Exchange Commission (SEC) and a futures commission merchant registered with the Commodity Futures Trading Commission (CFTC). Webull Financial is a member of the Financial Industry Authority (FINRA), the National Futures Association (NFA), and the Securities Investor Protection Corporation (SIPC). All investing is subject to risk, including the possible loss of principal. For more information about Webull, visit www.webull.com.
About Autonomix Medical, Inc.
Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body.
We are initially developing this technology for the treatment of pain, with initial trials focused on pancreatic cancer, a condition that causes debilitating pain and is without a reliable solution. Our technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Our technology is investigational and has not yet been cleared for marketing in the United States.
For more information, visit autonomix.com and connect with the Company on X, LinkedIn, Instagram and Facebook.
Investor and Media Contact
JTC Team, LLC
Jenene Thomas
(908) 824-0775
autonomix@jtcir.com
FAQ
When is Autonomix Medical (AMIX) presenting at the Webull Financial Biotech/MedTech Webinar?
Who will be presenting for Autonomix Medical (AMIX) at the Webull Financial Webinar?
What is Autonomix Medical's (AMIX) business focus?
What type of event is the Webull Financial Corporate Connect Webinar Series?
